In the treatment of SARS-CoV-2, the virus that causes COVID-19, antiviral drug remdesivir has emerged as a promising candidate. Remdesivir
Month: January 2021
A potentially safer, more effective gene therapy vector for blood disorders
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a gene therapy vector for blood disorders like sickle cell disease
Singles or pairs in cancer cells: The role of the CXCR4 receptor
It all sounds similar to a dance event—but are singles or couples dancing here? This was the question Ali Isbilir
Childhood trauma could affect development, treatment of multiple sclerosis
Childhood trauma could affect the trajectory of multiple sclerosis development and response to treatment in adulthood, a new study in
Researchers develop smartphone-based COVID-19 test that delivers results in about 10 minutes
Researchers at the University of Arizona are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva
How coronavirus damages lung cells within mere hours
What if scientists knew exactly what impact the SARS-CoV-2 virus had inside our lung cells, within the first few hours
EU regulator expects J&J vaccine application ‘shortly’
The EU’s medicines watchdog said on Friday that it expects Johnson and Johnson to submit an application for its coronavirus
A computational approach to understanding how infants perceive language
Languages differ in the sounds they use. The Japanese language, for example, does not distinguish between ‘r’ and ‘l’ sounds
Using artificial intelligence to predict which women will develop breast cancer
A team of researchers with members from institutions in the U.S., Sweden and Taiwan has developed an artificial intelligence system
Smoke- and tobacco-free policies grew more popular over time, even among tobacco users
Support for policies prohibiting smoking and the use of tobacco products on Oregon State University’s Corvallis campus grew substantially over
